Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Vaxcyte Inc. Common Stock (PCVX) vs Upwork Inc (UPWK) Price & Performance

Vaxcyte Inc. Common StockTrade
Upwork IncTrade

Price performance (Past 24H)

Key statistics

Vaxcyte Inc. Common Stock vs Upwork Inc — how do they compare? Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B), while Upwork Inc trades at $8.44 (market cap $1.08B). The key difference: Vaxcyte Inc. Common Stock is far larger — about 9.7× Upwork Inc's market cap, and Vaxcyte Inc. Common Stock is trading nearer its 52-week high, Upwork Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and Upwork Inc for 38 Days on average.

PCVXUPWK
Market Cap
$10.51B$1.08B
Volume
2,644,6942,181,968
Sector
HealthIndustrials
52-Week High
$73.82$22.11
52-Week Low
$40.32$7.84
Typical Hold Time
0 Days38 Days
Enterprise Value
$9.14B$842.37M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Vaxcyte Inc. Common Stock

No Aura AI signal available yet.

Upwork Inc

UPWK trades at $8.43, down 2.09% today, with mixed technical signals showing bullish moving averages but overbought RSI levels. The company maintains strong profitability with 77.21% gross margins and 12.93% net income margin, though recent earnings showed two misses out of three quarters. Revenue growth has slowed from 28.02% in 2024 to 14.65% in 2025, with Q3 2026 earnings pending. Institutional buying interest exists with Bank of America acquiring 704,083 shares in September 2026.

UPWK presents a compelling value case with low P/E of 11.08 and P/S of 1.49, trading below the $9.64 consensus target. However, AI disruption to freelance markets and declining active client counts pose significant risks. The stock offers 14% upside to analyst targets but faces execution challenges amid industry transformation.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PCVX
100% Buy0% Sell
Avg holding period · 0 Days
UPWK

No sentiment data available yet.

About Vaxcyte Inc. Common Stock

Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.

Read more on PCVX →

About Upwork Inc

Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with highly-skilled independent professionals. The develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to Clients.

Read more on UPWK →